Coya Therapeutics (COYA) EBT Margin (2023 - 2025)
Historic EBT Margin for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to 68.26%.
- Coya Therapeutics' EBT Margin changed N/A to 68.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 499.41%, marking a year-over-year decrease of 3886900.0%. This contributed to the annual value of 438.96% for FY2024, which is 3179400.0% down from last year.
- Per Coya Therapeutics' latest filing, its EBT Margin stood at 68.26% for Q3 2025.
- Coya Therapeutics' 5-year EBT Margin high stood at 30.24% for Q4 2023, and its period low was 209031.51% during Q4 2024.
- Over the past 3 years, Coya Therapeutics' median EBT Margin value was 2833.35% (recorded in 2025), while the average stood at 31385.06%.
- Per our database at Business Quant, Coya Therapeutics' EBT Margin crashed by 2000000000bps in 2024 and then skyrocketed by 11496100bps in 2025.
- Quarter analysis of 3 years shows Coya Therapeutics' EBT Margin stood at 30.24% in 2023, then plummeted by -691308bps to 209031.51% in 2024, then surged by 100bps to 68.26% in 2025.
- Its EBT Margin stands at 68.26% for Q3 2025, versus 3725.17% for Q2 2025 and 2833.35% for Q1 2025.